4th Quarter - Report

FEROX STRATEGIES for ALEXION PHARMACEUTICALS, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issue related to rare disease pharmaceuticals.

LobbyistCovered position, as disclosed
CRISTINA ANTELO —
DEBRA DIXON —
MARK WILLIAMS —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.